Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Interim Management Statement

12 May 2011 07:00

RNS Number : 4418G
Huntsworth PLC
12 May 2011
 



 

 

 

 

 

 

12 May 2011

 

 

Huntsworth plc

("Huntsworth" or "the Group")

Interim Management Statement 

 

Huntsworth Wins £15m of New Business

 

Huntsworth issues this Interim Management Statement to cover the period from 1 January 2011 to date.

 

Huntsworth, the public relations and healthcare communications Group, has won over £15m of new business since reporting full year results six weeks ago including a 27 country mandate for the European Union, a 17 country programme for DHL, and, the newly acquired Atomic, has been awarded the largest win in its history. As a result of these and other contract wins, committed revenues for the Group are now approximately 80% of 2011 full year forecasts on a strongly rising revenue stream.

 

As reported at the full year, management expects revenues to be heavily second half weighted as these large accounts come on stream, underpinning our revenue expectations for 2011 and giving added confidence in 2012 organic growth targets.

 

The balance sheet remains robust with net debt comfortably within banking covenants.

 

 

Grayling

 

Following the 38 country win of British Airways announced in March, Grayling has seen increased client interest in its international capabilities. DHL, the international carrier company, has appointed Grayling in 17 countries and the European Union has appointed Grayling to handle a three year, six million euro, 27 member state anti-smoking campaign and OMV, Central Europe's leading oil and gas supplier, has expanded its relationship into six countries.

 

Atomic has been awarded a seven figure fee account - the largest in its history - and has already made seven international pitches alongside their new Grayling colleagues.

 

 

Huntsworth Health

 

Huntsworth Health has been appointed by a top ten Pharma company to prepare for the launch of a novel new oncology product. Another top ten Pharma has added Huntsworth to its preferred supplier lists for global assignments in both medical education and medical communications. In addition Huntsworth Health was invited to participate as a member of a new independent network to pitch for 13 individual therapeutic categories at a top ten pharma.

  

 

Citigate

 

Citigate continues to build on its position as a leading M&A advisory consultancy and was recently ranked 5th globally by volume in the mergermarket league table. Current projects in the UK include transaction work for the London Stock Exchange, the Yorkshire Building Society and Chaucer Holdings. Internationally Citigate has won a number of new accounts, including the Malaysian Smelting Company and the state of Ontario, Canada in support of its international investment and trade programmes in China.

 

 

Red

 

RED has 90% of its 2011 budget committed and has added more blue chip names to its UK client list - including 20th Century Fox, Schweppes Abbey Well and Gatwick Airport.

 

 

 

Peter Chadlington, Huntsworth CEO, commented "As a direct result of the reorganisation of the Group, we are beginning to see real momentum throughout the Group as the number of global and international opportunities increase significantly. We are confident that we will meet management expectations for 2011 and believe that we are now on course for good organic growth in 2012."

  

 

 

 

Enquiries to:

 

Huntsworth PLC +44 (0)207 224 8778

Peter Chadlington, Chief Executive

Colin Adams, Group Finance Director

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Simon Rigby

Angharad Couch

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKDDQKBKBCPD
Date   Source Headline
31st Mar 20149:41 amRNSHuntsworth plc Notice of Preliminary Results
13th Dec 20137:00 amRNSAtomic merges with Grayling
2nd Dec 20139:37 amRNSBlocklisting Interim Review
2nd Dec 20139:34 amRNSTotal Voting Rights
28th Nov 20133:55 pmRNSAdditional Listing
13th Nov 20137:00 amRNSInterim Management Statement
8th Nov 201311:29 amRNSDirector/PDMR Shareholding
5th Nov 201312:40 pmRNSAdditional Listing
1st Nov 20139:51 amRNSTotal Voting Rights
25th Oct 20134:19 pmRNSHolding(s) in Company - Replacement
25th Oct 20132:09 pmRNSHolding(s) in Company
23rd Oct 20134:40 pmRNSHolding(s) in Company
15th Oct 20134:35 pmRNSPrice Monitoring Extension
14th Oct 20139:45 amRNSHolding(s) in Company
11th Oct 201311:27 amRNSHolding(s) in Company
10th Oct 201312:45 pmRNSTotal Voting Rights
9th Oct 201312:20 pmRNSScrip Dividend Alternative
7th Oct 20138:22 amRNSCompletion of Subscription & Director Appointment
4th Oct 201311:05 amRNSResult of GM
30th Sep 20135:14 pmRNSDirector/PDMR Shareholding
18th Sep 20134:12 pmRNSPublication of Prospectus
21st Aug 20134:22 pmRNSUpdate on proposed investment
9th Aug 20133:00 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNSInterim results for the six months to 30 June 2013
1st Aug 201310:57 amRNSTotal Voting Rights
29th Jul 20132:30 pmRNSNotice of results & update on proposed investment
5th Jul 201311:56 amRNSDirector/PDMR Shareholding
3rd Jul 20131:38 pmRNSAdditional Listing
1st Jul 20139:38 amRNSTotal Voting Rights
28th Jun 201311:37 amRNSHolding(s) in Company
26th Jun 20134:15 pmRNSTreasury Stock
26th Jun 201311:26 amRNSHolding(s) in Company
24th Jun 20137:00 amRNSHuntsworth to appoint first CEO for Asia-Pacific
20th Jun 20134:56 pmRNSAdditional Listing
13th Jun 201311:38 amRNSResult of AGM
5th Jun 201312:05 pmRNSScrip Dividend Alternative
3rd Jun 20131:15 pmRNSBlocklisting Interim Review
17th May 20137:00 amRNSInterim Management Statement
14th May 20139:43 amRNSNotice of AGM
2nd May 201311:03 amRNSHolding(s) in Company
1st May 20138:56 amRNSTotal Voting Rights
30th Apr 20135:31 pmRNSAnnual Financial Report
29th Apr 20131:38 pmRNSTreasury Stock
26th Apr 20135:34 pmRNSHolding(s) in Company
26th Apr 20132:26 pmRNSDirector/PDMR Shareholding
25th Apr 20138:39 amRNSReplacement: Final Results
25th Apr 20137:01 amRNSBLUEFOCUS TO INVEST £36.5m in HUNTSWORTH
25th Apr 20137:00 amRNSFinal Results
4th Apr 20137:00 amRNSNotice of Results
5th Feb 20137:00 amRNSPre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.